Getein Biotech Inc
医疗健康 · 医疗器械
Getein Biotech, Inc researches, develops, produces, and sells in vitro diagnostic reagents and instruments in China and internationally. The company provides point-of-care detection, chemiluminescence detection, biochemical analysis, molecular testing, thrombus and hemostasis detection, blood cell analysis detection, urine analysis, quality control products, diagnostic raw materials, biochemical immunity, and other fields, such as myocardium, inflammation, renal function, thyroid function, hormones, glucose metabolism, tumor, coagulation, blood cells detection. The company was founded in 2002 and is headquartered in Nanjing, China.
MARKET 市值 4.17B CNY PE 17.9x
52W ¥7.37 – ¥11.42
EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG — 营收 YoY 9.6%
▲ ROE 7.8% 营业利润率 28.2% 净利润率 21.6%
ANALYST 股息率 2.96%